Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital Tuebingen
With
University Hospital Heidelberg
Charite University, Berlin, Germany
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients ≥ 18 years of age
Male or female
Patients having pigmented lesions with suspicion of dysplastic nevus or melanoma, in whom an excision is performed in order to exclude or diagnose malignant melanoma
Patients who gave their written informed consent.
You may not be if
Patients with skin type V and VI according to Fitzpatrick's scale;
Where there is a risk that the scanning head is torn off be-cause the patient cannot be placed at rest (e.g. due to motoric disorders like tremor, convulsions, tics, compulsive acts
Patients who cannot understand the patient information and provide informed consent
Deep dermal lesions ≥ 5 mm beneath the stratum corneum
Clinically or reflected-light microscopically obviously non-melanocytic lesions
Peri- and subungual lesions
Mucosal lesions
Lesions with trauma, erosion (superficial defect), excoriation (defect down to the basement membrane) or ulceration (deep substantial defect) on more than 50 % of the lesion area (measurements must in any case not be carried out directly on the trauma, erosion, excoriation or ulceration)
Tattooed lesions
Pregnant or breast feeding women
Patients suffering from albinism
Lesions with dominant (\>50%) regression
Lesions which are not suitable to fix the scanning cap
Clareo Health | FLuorescence Identification of Melanoma by a Multicenter Based Algorithm (FLIMMA)
